Tue Dec 9, 2014 9:36pm IST (Reuters) - Shares of drug developer bluebird bio Inc shot up on Tuesday, after the company presented data that showed a cure for beta-thalassemia is within reach, prompt...
Bluebird shares leap after gene therapy seen as cure for blood disorder
Thursday, 11 December 2014
Bluebird shares leap after gene therapy seen as cure for blood disorder
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment